Integration of RNA-Seq and Machine Learning Identifies Hub Genes for Empagliflozin Benefitable Heart Failure with Reduced Ejection Fraction
Qiang Yang,1,* Jing Gao,2,* Tian-Yu Wang,1 Jun-Can Ding,1 Peng-Fei Hu3 1Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, 310053, People’s Republic of China; 2Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine Zhe...
Main Authors: | Yang Q, Gao J, Wang TY, Ding JC, Hu PF |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-10-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/integration-of-rna-seq-and-machine-learning-identifies-hub-genes-for-e-peer-reviewed-fulltext-article-JIR |
Similar Items
-
Identification of Key Immune-Related Genes in the Treatment of Heart Failure After Myocardial Infarction with Empagliflozin Based on RNA-Seq
by: Zhang P, et al.
Published: (2023-10-01) -
Dapagliflozin and Empagliflozin in Heart Failure with Reduced Ejection Fraction: A Retrospective Study
by: Hao Z, et al.
Published: (2022-07-01) -
Cost-Effectiveness Evaluation of Add-on Empagliflozin in Patients With Heart Failure and a Reduced Ejection Fraction From the Healthcare System's Perspective in the Asia-Pacific Region
by: Chia-Te Liao, et al.
Published: (2021-10-01) -
Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
by: Abdallah Al‐Mohammad
Published: (2019-08-01) -
Cost-effectiveness of empagliflozin for the treatment of heart failure with reduced ejection fraction in China
by: Haiqiang Sang, et al.
Published: (2022-11-01)